182 related articles for article (PubMed ID: 26773517)
1. IRS-1 Functions as a Molecular Scaffold to Coordinate IGF-I/IGFBP-2 Signaling During Osteoblast Differentiation.
Xi G; Shen X; Rosen CJ; Clemmons DR
J Bone Miner Res; 2016 Jun; 31(6):1300-14. PubMed ID: 26773517
[TBL] [Abstract][Full Text] [Related]
2. The coordinate cellular response to insulin-like growth factor-I (IGF-I) and insulin-like growth factor-binding protein-2 (IGFBP-2) is regulated through vimentin binding to receptor tyrosine phosphatase β (RPTPβ).
Shen X; Xi G; Wai C; Clemmons DR
J Biol Chem; 2015 May; 290(18):11578-90. PubMed ID: 25787077
[TBL] [Abstract][Full Text] [Related]
3. IGFBP-2 directly stimulates osteoblast differentiation.
Xi G; Wai C; DeMambro V; Rosen CJ; Clemmons DR
J Bone Miner Res; 2014 Nov; 29(11):2427-38. PubMed ID: 24839202
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor (IGF) binding protein 2 functions coordinately with receptor protein tyrosine phosphatase β and the IGF-I receptor to regulate IGF-I-stimulated signaling.
Shen X; Xi G; Maile LA; Wai C; Rosen CJ; Clemmons DR
Mol Cell Biol; 2012 Oct; 32(20):4116-30. PubMed ID: 22869525
[TBL] [Abstract][Full Text] [Related]
5. Estrogen Stimulation of Pleiotrophin Enhances Osteoblast Differentiation and Maintains Bone Mass in IGFBP-2 Null Mice.
Xi G; Demambro VE; D'Costa S; Xia SK; Cox ZC; Rosen CJ; Clemmons DR
Endocrinology; 2020 Apr; 161(4):. PubMed ID: 32168373
[TBL] [Abstract][Full Text] [Related]
6. IGF-I and IGFBP-2 Stimulate AMPK Activation and Autophagy, Which Are Required for Osteoblast Differentiation.
Xi G; Rosen CJ; Clemmons DR
Endocrinology; 2016 Jan; 157(1):268-81. PubMed ID: 26556533
[TBL] [Abstract][Full Text] [Related]
7. IGFBP-2 stimulates calcium/calmodulin-dependent protein kinase kinase 2 activation leading to AMP-activated protein kinase induction which is required for osteoblast differentiation.
Xi G; D'Costa S; Wai C; Xia SK; Cox ZC; Clemmons DR
J Cell Physiol; 2019 Dec; 234(12):23232-23242. PubMed ID: 31155724
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor-I-stimulated insulin receptor substrate-1 negatively regulates Src homology 2 domain-containing protein-tyrosine phosphatase substrate-1 function in vascular smooth muscle cells.
Radhakrishnan Y; Busby WH; Shen X; Maile LA; Clemmons DR
J Biol Chem; 2010 May; 285(21):15682-95. PubMed ID: 20207740
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor-binding protein-2 is required for osteoclast differentiation.
DeMambro VE; Maile L; Wai C; Kawai M; Cascella T; Rosen CJ; Clemmons D
J Bone Miner Res; 2012 Feb; 27(2):390-400. PubMed ID: 22006816
[TBL] [Abstract][Full Text] [Related]
10. Involvement of ligand occupancy in Insulin-like growth factor-I (IGF-I) induced cell growth in osteoblast like MC3T3-E1 cells.
Kim SK; Kwon JY; Nam TJ
Biofactors; 2007; 29(4):187-202. PubMed ID: 18057550
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of insulin-like growth factor-1 (IGF-1) expression by prolonged transforming growth factor-β1 (TGF-β1) administration suppresses osteoblast differentiation.
Ochiai H; Okada S; Saito A; Hoshi K; Yamashita H; Takato T; Azuma T
J Biol Chem; 2012 Jun; 287(27):22654-61. PubMed ID: 22573330
[TBL] [Abstract][Full Text] [Related]
12. Identification of the amino acids 300-600 of IRS-2 as 14-3-3 binding region with the importance of IGF-1/insulin-regulated phosphorylation of Ser-573.
Neukamm SS; Toth R; Morrice N; Campbell DG; Mackintosh C; Lehmann R; Haering HU; Schleicher ED; Weigert C
PLoS One; 2012; 7(8):e43296. PubMed ID: 22912850
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor-1 (IGF-1) receptor-insulin receptor substrate complexes in the uterus. Altered signaling response to estradiol in the IGF-1(m/m) mouse.
Richards RG; Walker MP; Sebastian J; DiAugustine RP
J Biol Chem; 1998 May; 273(19):11962-9. PubMed ID: 9565625
[TBL] [Abstract][Full Text] [Related]
14. The heparin-binding domain of IGFBP-2 has insulin-like growth factor binding-independent biologic activity in the growing skeleton.
Kawai M; Breggia AC; DeMambro VE; Shen X; Canalis E; Bouxsein ML; Beamer WG; Clemmons DR; Rosen CJ
J Biol Chem; 2011 Apr; 286(16):14670-80. PubMed ID: 21372140
[TBL] [Abstract][Full Text] [Related]
15. Phosphatidylinositol 3-kinase (PI3K) activity bound to insulin-like growth factor-I (IGF-I) receptor, which is continuously sustained by IGF-I stimulation, is required for IGF-I-induced cell proliferation.
Fukushima T; Nakamura Y; Yamanaka D; Shibano T; Chida K; Minami S; Asano T; Hakuno F; Takahashi S
J Biol Chem; 2012 Aug; 287(35):29713-21. PubMed ID: 22767591
[TBL] [Abstract][Full Text] [Related]
16. AMP-activated protein kinase inhibits IGF-I signaling and protein synthesis in vascular smooth muscle cells via stimulation of insulin receptor substrate 1 S794 and tuberous sclerosis 2 S1345 phosphorylation.
Ning J; Clemmons DR
Mol Endocrinol; 2010 Jun; 24(6):1218-29. PubMed ID: 20363874
[TBL] [Abstract][Full Text] [Related]
17. Platelet-derived growth factor negatively regulates the insulin-like growth factor signaling pathway through the coordinated action of phosphatidylinositol 3-kinase and protein kinase C beta I.
Lassarre C; Legay C; Karam M; Ricort JM
Biochim Biophys Acta; 2013 Jun; 1833(6):1367-77. PubMed ID: 23481042
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of insulin-like growth factor signaling pathways in mammary gland by pure antiestrogen ICI 182,780.
Chan TW; Pollak M; Huynh H
Clin Cancer Res; 2001 Aug; 7(8):2545-54. PubMed ID: 11489838
[TBL] [Abstract][Full Text] [Related]
19. Insulin receptor substrate (IRS) proteins IRS-1 and IRS-2 differential signaling in the insulin/insulin-like growth factor-I pathways in fetal brown adipocytes.
Valverde AM; Lorenzo M; Pons S; White MF; Benito M
Mol Endocrinol; 1998 May; 12(5):688-97. PubMed ID: 9605931
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor-binding protein-2 promotes prostate cancer cell growth via IGF-dependent or -independent mechanisms and reduces the efficacy of docetaxel.
Uzoh CC; Holly JM; Biernacka KM; Persad RA; Bahl A; Gillatt D; Perks CM
Br J Cancer; 2011 May; 104(10):1587-93. PubMed ID: 21487405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
